(Q35067114)

6 August 2017

1 reference

title

The cytokine network in sarcoidosis and its clinical relevance (English)

1 reference

6 August 2017

Ziegenhagen MW

1

1 reference

6 August 2017

Müller-Quernheim J

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Journal of Internal Medicine

6 August 2017

1 reference

6 August 2017

253

1 reference

6 August 2017

18-30

1 reference

6 August 2017

1

1 reference

Cellular and molecular aspects of granulomatous inflammation

6 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Th1 and Th2 in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Cloning of a new cytokine that induces IFN-gamma production by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Human leukocyte antigen genes may outweigh racial background when generating a specific immune response in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Purification of Type I and Type II Tumor Necrosis Factor Receptors from Human Lung Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01074.X

10.1046/J.1365-2796.2003.01074.X

21 January 2018

Identifiers

DOI

1 reference

release_cnev26a42rczfemmfzwx3hlk7i

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cnev26a42rczfemmfzwx3hlk7i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference